These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 17122688)
1. Emerging new therapies in rheumatoid arthritis: what's next for the patient? Leff L J Infus Nurs; 2006; 29(6):326-37. PubMed ID: 17122688 [TBL] [Abstract][Full Text] [Related]
2. A nursing guide to infusion therapy with abatacept for the treatment of rheumatoid arthritis. Barr C J Infus Nurs; 2007; 30(2):96-104; quiz 120. PubMed ID: 17413494 [TBL] [Abstract][Full Text] [Related]
3. Immunopathogenic Mechanisms and Novel Immune-Modulated Therapies in Rheumatoid Arthritis. Chen SJ; Lin GJ; Chen JW; Wang KC; Tien CH; Hu CF; Chang CN; Hsu WF; Fan HC; Sytwu HK Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884802 [TBL] [Abstract][Full Text] [Related]
4. Rheumatoid arthritis: an overview of new and emerging therapies. Doan T; Massarotti E J Clin Pharmacol; 2005 Jul; 45(7):751-62. PubMed ID: 15951465 [TBL] [Abstract][Full Text] [Related]
5. New therapeutic options in rheumatoid arthritis: a focus on interleukin-6 blockade. Furfaro N J Infus Nurs; 2011; 34(2):107-15. PubMed ID: 21399456 [TBL] [Abstract][Full Text] [Related]
6. Current immunotherapy in rheumatoid arthritis. Meier FM; Frerix M; Hermann W; Müller-Ladner U Immunotherapy; 2013 Sep; 5(9):955-74. PubMed ID: 23998731 [TBL] [Abstract][Full Text] [Related]
7. Joint inflammation and cytokine inhibition in rheumatoid arthritis. Christodoulou C; Choy EH Clin Exp Med; 2006 Mar; 6(1):13-9. PubMed ID: 16550339 [TBL] [Abstract][Full Text] [Related]
8. Immunological therapies for rheumatoid arthritis. Edwards CJ Br Med Bull; 2005; 73-74():71-82. PubMed ID: 16174791 [TBL] [Abstract][Full Text] [Related]
9. Specific therapy to regulate inflammation in rheumatoid arthritis: molecular aspects. García-Hernández MH; González-Amaro R; Portales-Pérez DP Immunotherapy; 2014; 6(5):623-36. PubMed ID: 24896630 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-22 and rheumatoid arthritis: emerging role in pathogenesis and therapy. Xie Q; Huang C; Li J Autoimmunity; 2015 Mar; 48(2):69-72. PubMed ID: 25483133 [TBL] [Abstract][Full Text] [Related]
14. New concepts in the treatment of rheumatoid arthritis. Goldbach-Mansky R; Lipsky PE Annu Rev Med; 2003; 54():197-216. PubMed ID: 12359827 [TBL] [Abstract][Full Text] [Related]
15. Differential Effects of Inflammation on Bone and Response to Biologics in Rheumatoid Arthritis and Spondyloarthritis. Stavre Z; Upchurch K; Kay J; Gravallese EM Curr Rheumatol Rep; 2016 Dec; 18(12):72. PubMed ID: 27812955 [TBL] [Abstract][Full Text] [Related]
16. Are biological targets the final goal for rheumatoid arthritis therapy? Sharma P; Pathak K Expert Opin Biol Ther; 2012 Dec; 12(12):1611-22. PubMed ID: 22954024 [TBL] [Abstract][Full Text] [Related]
17. Introduction to economic modeling for clinical rheumatologists: application to biologic agents in rheumatoid arthritis. Marra CA; Bansback N; Anis AH; Shojania K Clin Rheumatol; 2011 Mar; 30 Suppl 1():S9-18. PubMed ID: 21359506 [TBL] [Abstract][Full Text] [Related]
18. Treating to target in rheumatoid arthritis: biologic therapies. Firth J; Critchley S Br J Nurs; 2011 Nov 10-23; 20(20):1284, 1287-8, 1290-1. PubMed ID: 22068002 [TBL] [Abstract][Full Text] [Related]
19. [Present importance of direct immunologically based intervention strategies using anticytokines in rheumatoid arthritis]. Boehme MW; Gao IK Z Rheumatol; 1999 Oct; 58(5):251-66. PubMed ID: 10591973 [TBL] [Abstract][Full Text] [Related]